Back to Search Start Over

Stroke with Transfusions Changing to Hydroxyurea (SWiTCH): A Phase 3 Randomized Clinical Trial for Treatment of Children with Sickle Cell Anemia, Previous Stroke, and Iron Overload

Authors :
Ware, Russell E.
Helms, Ronald W
Source :
Blood; November 2010, Vol. 116 Issue: 21 p844-844, 1p
Publication Year :
2010

Abstract

Off Label Use: Hydroxyurea is used to reduce complications of sickle cell anemia.

Details

Language :
English
ISSN :
00064971 and 15280020
Volume :
116
Issue :
21
Database :
Supplemental Index
Journal :
Blood
Publication Type :
Periodical
Accession number :
ejs52983469
Full Text :
https://doi.org/10.1182/blood.V116.21.844.844